Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $123,908 | 81 | 74.5% |
| Food and Beverage | $23,174 | 856 | 13.9% |
| Travel and Lodging | $15,575 | 67 | 9.4% |
| Consulting Fee | $3,700 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $88,849 | 213 | $0 (2022) |
| ABBVIE INC. | $31,400 | 213 | $0 (2024) |
| Allergan, Inc. | $21,298 | 89 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $10,962 | 34 | $0 (2024) |
| Boston Scientific Corporation | $2,029 | 11 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $1,191 | 23 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $1,076 | 65 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $924.74 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $875.30 | 40 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $740.92 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,238 | 78 | ABBVIE INC. ($882.31) |
| 2023 | $15,024 | 93 | Otsuka America Pharmaceutical, Inc. ($10,655) |
| 2022 | $36,273 | 124 | Avanir Pharmaceuticals, Inc. ($18,263) |
| 2021 | $20,161 | 81 | AbbVie Inc. ($9,839) |
| 2020 | $22,251 | 116 | Allergan, Inc. ($20,820) |
| 2019 | $52,700 | 276 | Avanir Pharmaceuticals, Inc. ($47,217) |
| 2018 | $15,010 | 128 | Avanir Pharmaceuticals, Inc. ($13,066) |
| 2017 | $2,700 | 109 | Sunovion Pharmaceuticals Inc. ($737.54) |
All Payment Transactions
1,005 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: PAIN | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: NEUROLOGY | ||||||
| 08/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 584 | 1,264 | $316,989 | $83,024 |
| 2022 | 10 | 568 | 1,309 | $315,638 | $78,853 |
| 2021 | 10 | 657 | 1,453 | $338,665 | $88,534 |
| 2020 | 11 | 753 | 1,620 | $369,925 | $94,150 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 653 | $139,742 | $37,947 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 91 | 146 | $44,822 | $11,619 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 89 | $53,133 | $11,579 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 106 | $22,048 | $6,324 | 28.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 62 | 62 | $13,268 | $3,768 | 28.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 40 | $12,600 | $3,359 | 26.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 28 | $8,596 | $2,285 | 26.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $7,392 | $1,904 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,168 | $1,756 | 34.0% |
| 97542 | Evaluation for wheelchair, each 15 minutes | Office | 2023 | 31 | 69 | $6,624 | $1,391 | 21.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 31 | $3,596 | $1,092 | 30.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 101 | 686 | $146,804 | $35,845 | 24.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 86 | 91 | $54,327 | $13,240 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 125 | $38,375 | $10,817 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 90 | $18,720 | $5,373 | 28.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 84 | 85 | $18,190 | $4,379 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $13,552 | $2,937 | 21.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 40 | 92 | $10,672 | $2,623 | 24.6% |
| 97542 | Evaluation for wheelchair, each 15 minutes | Office | 2022 | 33 | 70 | $6,720 | $1,255 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,553 | $1,207 | 34.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 15 | $4,725 | $1,176 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 120 | 692 | $148,088 | $38,146 | 25.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 102 | 105 | $62,685 | $16,047 | 25.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 144 | $29,952 | $9,118 | 30.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 83 | $25,481 | $7,118 | 27.9% |
About Dr. Heidi Hunter, MD
Dr. Heidi Hunter, MD is a Physical Medicine & Rehabilitation healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992917785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Hunter, MD has received a total of $166,357 in payments from pharmaceutical and medical device companies, with $2,238 received in 2024. These payments were reported across 1,005 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($123,908).
As a Medicare-enrolled provider, Hunter has provided services to 2,562 Medicare beneficiaries, totaling 5,646 services with total Medicare billing of $344,561. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Cape Girardeau, MO
- Active Since 05/04/2007
- Last Updated 06/29/2011
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992917785
Products in Payments
- NUEDEXTA (Drug) $81,454
- UBRELVY (Drug) $48,108
- Nuedexta (Drug) $18,263
- QULIPTA (Drug) $3,228
- WATCHMAN (Device) $2,029
- APTIOM (Drug) $1,191
- TROKENDI XR (Drug) $1,005
- EPIDIOLEX (Drug) $890.81
- VRAYLAR (Drug) $655.88
- NURTEC ODT (Drug) $549.78
- Horizant (Drug) $431.50
- GILENYA (Drug) $428.27
- Aimovig (Biological) $366.50
- Vimpat (Drug) $362.91
- Mavenclad (Biological) $313.77
- INGREZZA (Drug) $275.94
- AUBAGIO (Drug) $268.86
- XCOPRI (Drug) $248.70
- AJOVY (Drug) $245.01
- Briviact (Drug) $233.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Cape Girardeau
Mrs. Gladys Grace Kamanga-Sollo, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,939
Bernard Burns, Do, DO
Physical Medicine & Rehabilitation — Payments: $904.63
Matthew Karshner, Md, MD
Physical Medicine & Rehabilitation — Payments: $698.19
Dr. Paul Guidos, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $424.13
Im Hong, Md, MD
Physical Medicine & Rehabilitation — Payments: $322.19
Anna Guidos, Md, MD
Physical Medicine & Rehabilitation